COVID infection and action on body: This paper... - Thyroid UK

Thyroid UK

141,246 members166,490 posts

COVID infection and action on body

diogenes profile image
diogenesRemembering
9 Replies

This paper compares the vital signs of patients with COVID sick syndrome and controls. Of the parameters measured, FT4 and (F)T3, and inflammation markers CRP and ESR changed significantly between the two groups. FT4 and FT3 declined significantly, and CRP and ESR rose significantly. TSH did not change significantly. Therefore COVID disease is a form of nonthyroidal illness, but TSH is not altered. Another incidence of thyroid hormones being the most significant indicators.

Front. Endocrinol., 07 October 2020 | doi.org/10.3389/fendo.2020....

Euthyroid Sick Syndrome in Patients With COVID-19

Runmei Zou, Chenfang Wu, Siye Zhang, Guyi Wang, Quan Zhang, Bo Yu, Ying Wu, Haiyun Dong, Guobao Wu, Shangjie Wu and Yanjun Zhong

Written by
diogenes profile image
diogenes
Remembering
To view profiles and participate in discussions please or .
Read more about...
9 Replies
LindaC profile image
LindaC

As always, thank you - much appreciated.

Hillwoman profile image
Hillwoman

Thank you.

jimh111 profile image
jimh111

There have been a number of studies showing non-thyroidal illness (NTI) in COVID-19 patients. This study restricted the diagnosis of Euthyroid Sick Syndrome (now called NTI or 'low T3 syndrome') to hospitalised patients with an fT3 < 2.3 pg/ml (no reference interval was given in the paper). Patients with NTI and an fT3 above 2.3 pg/ml are omitted from the study.

Other studies have adopted the 'reflex' thyroid testing strategy (an abomination). This is where fT3 and fT4 are tested only if TSH falls below its lower limit. This strategy fails to identify the majority of NTI cases, patients with a lowered fT3 and low normal TSH.

A further complication is that a minority of COVID-19 patients develop subaccute thyroiditis, they become thyrotoxic for a short period. This confounds the results, especially fT4 due to thyroxine's long half life.

I'm lobbying for a study of NTI in athyroetic COVID-19 patients receiving levothyroxine monotherapy. If the patients don't have a thyroid the results won't be distorted by COVID-19 effects on the thyroid. It would also be beneficial to measure TSH isoforms in these patients and compare with controls. This might give a clue as to which forms of TSH affect deiodinase. It gives a unique opportunity to explain why some patients have poor T4 to T3 conversion.

I will ask the American Thyroid Association (ATA) to support this research as the USA has high COVID-19 infection rates. There's no harm in asking!

helvella profile image
helvellaAdministrator in reply tojimh111

Best of luck with that.

I do agree that, however terrible, it does offer opportunities. But that is only any good if people pick them up and run.

jimh111 profile image
jimh111 in reply tohelvella

They tend not to run with the ball. They don't drop it, they tend not to even see it. I'll keep trying on the dripping tap principle.

UrsaP profile image
UrsaP

Thank you diogenes and all.

linda96 FYI

Musicmonkey profile image
Musicmonkey

Thank you diogenes Much appreciated

grauntieannie profile image
grauntieannie

Thank you, Diogenes.

Jumbelina profile image
Jumbelina

Thank you Diogenes- very useful to know

Not what you're looking for?

You may also like...

Covid and the thyroid

This paper discusses the action of COVID on thyroid expression. Downloadable. Front....
diogenes profile image
Remembering

Changes of bone mineral density and bone metabolic marker in patients with subclinical hypothyroidism

Can someone please explain why medics are utterly obsessed with over-treatment causing lowered bone...
helvella profile image
Administrator

Low serum free thyroxine level is correlated with lipid profile in depressive patients with suicide attempt

I really don't know what to say about this abstract. Unless I am getting it entirely wrong, don't...
helvella profile image
Administrator

The long-term prognostic implications of free triiodothyronine to free thyroxine ratio in patients with obstructive sleep apnea and ACS

Another paper reporting FT3/FT4 ratio as a relevant factor. In this case, wiuth quite serious...
helvella profile image
Administrator

useful 'Evidence' that TSH between 0.04 - 0.4 has no increased risk to patients on Levothyroxine (UPDATED~new study does show small risk)

This paper forms part of the evidence base for the current NHS thyroid treatment guidelines , it...
tattybogle profile image